Delivery Order SPE2DB22D9316-SPE2DB25FYP85
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,434.34 by the Defense Logistics Agency on July 30, 2025, for the supply of Cabometyx 60 mg tablets (30-count units). The delivery order is issued without a set-aside designation and is scheduled for completion by July 31, 2025. This award falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,483.21 by the Defense Logistics Agency (DLA) for the supply of Cabometyx 40 mg tablets (30-count packages). This firm fixed-price delivery order, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a discrete purchase under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $33,265.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 20 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a direct pharmaceutical supply fulfillment under DLA's pharmaceutical distribution operations. DMS...
- The U.S. Defense Logistics Agency awarded a delivery order valued at $16,483.21 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 40 mg tablets (30-count units). This award, issued on August 19, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and will be performed at the contractor's facility in Park Ridge, Illinois. The contract utilizes no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $15,221.97 under an indefinite delivery contract with the Defense Logistics Agency to supply Cabometyx 40 mg tablets. As a woman-owned small business, DMS Pharmaceutical Group will deliver 30 tablets of Cabometyx to the Park Ridge, Illinois location of the Defense Logistics Agency Troop Support Medical by November 9, 2023. DMS Pharmaceutical Group currently supplies pharmaceuticals and medical products in...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $83,162.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 20 mg tablets (30-count units). This delivery order was issued without a set-aside designation on August 11, 2025, with an ultimate completion date of August 12, 2025. The award represents a discrete purchase order under DMS Pharmaceutical Group's larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $15,221.97, is for the supply of the drug Cabometyx 40mg tablets. It is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order, contract SPE2DB24FSW72, to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $15,409.02 order is for the supply of Cabometyx 40 mg tablets. This delivery order is part of a larger indefinite-delivery vehicle (IDV), contract SPE2DB22D9367, with DMS Pharmaceutical Group that has a ceiling value of up to $4,999,999 through 2025. The IDV allows DLA to issue delivery...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide Cabometyx 60 mg tablets. The $30,346.64 order calls for 30 tablets to be delivered by October 30, 2023 to the Park Ridge, Illinois location. No set-aside designation was used for this order issued against DMS Pharmaceutical Group's existing pharmaceutical prime vendor contract vehicle with the DLA, which has a potential value of up...
- This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $15,221.97 contract was awarded by the Defense Logistics Agency (DLA) to supply the drug CABOMETYX 40 MG TABLET 30S. This delivery order is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which covers a wide range of pharmaceutical products for military health facilities...
- SPE2DB22D9316Indefinite Delivery Contract
- SPE2DB22D9316-SPE2DB25FYP85Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on August 25, 2025, for Cabometyx 40 mg tablets (30-count units). This firm fixed-price delivery order, valued at approximately $33k, represents a single purchase action issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500M vehicle valid through November 2026. The award carries no set-aside designation, and the place of performance is located at the contractor's facility in Park Ridge, Illinois, with an ultimate completion date of August 26, 2025. Cabometyx (cabozantinib) is an oncology therapeutic used in the treatment of advanced renal cell carcinoma and other malignancies, reflecting the DLA's broader mission to supply pharmaceutical products supporting medical needs across Department of Defense healthcare facilities worldwide. This delivery order exemplifies DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, providing branded and specialty medications to military health systems. The company's extensive contract portfolio with the DLA demonstrates consistent capability in delivering complex pharmaceutical products to support DOD medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.0k | 8/25/25 |